Arthritis & Rheumatism · 1992 · 177 citations · 45 references
Life SciencesImmunologyPathobiologyAutoimmunityCellular ImmunologyImmunopathologyAutoimmune Disease PathogenesisAutoimmune DiseasesAutoimmune PathogenesisAutoimmune Rheumatic DiseasesSystemic Autoimmune DiseaseSystemic Lupus ErythematosusAutoreactive T Cell ResponsesCd4 Positive T CellsCd4 T Cell ActivationSystemic Lupus Erythematosus AssociationsT-cell Mediated Autoimmunity
OBJECTIVE: Antigen-specific CD4+ T cells treated with DNA methylation inhibitors become autoreactive, suggesting a novel mechanism for autoimmunity. To test whether this mechanism might be involved in systemic lupus erythematosus (SLE), phenotypic markers for the autoreactive cells were sought. METHODS: Cloned normal T cells were treated with the DNA methylation inhibitor 5-azacytidine (5-azaC) and studied for altered gene expression. T cells from patients with active SLE were then studied for a similar change in gene expression, and cells expressing the marker were tested for autoreactivity. RESULTS: 5-azaC-treated normal T cells had increased CD11a (leukocyte function-associated antigen 1 alpha) expression relative to other membrane molecules. A T cell subset with similar CD11a expression was found in patients with active SLE. This subset contained cells that spontaneously lysed autologous macrophages, with a specificity similar to that of 5-azaC-treated cells.
45
The 1982 revised criteria for the classification of systemic lupus erythematosus
Eng M. Tan, Alan S. Cohen, James F. Fries et al. · Arthritis & Rheumatism · 1982 · 14.6K citations
A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1.
Robert Rothlein, Michael L. Dustin, Sandrine Marlin et al. · The Journal of Immunology · 1986 · 1.4K citations